Category: Uncategorized

JanOne Advances its Potential Peripheral Artery Disease and Covid-19 Vascular Inflammation Treatment Towards Trial Readiness

August 26, 2020

JanOne to Host Telebriefing to Discuss Drug Candidate JAN101 for Treatment of Peripheral Artery Disease (PAD) and Potential Applications for COVID-19 Vascular Complications

August 21, 2020

JanOne to Present at The LD 500 Virtual Conference

August 19, 2020

JanOne Completes Stable Formulation of JAN101 in Preparation for Its First GMP Manufacturing Batch to Support Upcoming Clinical Trials

August 11, 2020

JanOne Engages CATO SMS, a World-Leading CRO, to Assist in the Development of JAN101 to Treat COVID-19 Vascular Complications

August 6, 2020

JanOne Changes Internal Drug Candidate Name from TV1001SR to JAN101

August 4, 2020

JanOne bolsters its scientific advisory board with two leaders in the medical field for vascular regeneration and interventional pain

July 30, 2020

JanOne Receives FDA Authorization for Transfer of Investigational New Drug (IND) Application for its Sodium Nitrite Tablets

July 21, 2020

Dr. Rakesh Patel, internationally recognized scientist in nitric oxide and redox biology, and Dr. Timothy Ness, a pain mechanisms and medication expert, join JanOne’s Scientific Advisory Board

July 8, 2020

One of the nation’s most renowned pain experts, Dr. Edgar Ross, joins JanOne’s Scientific Advisory Board

June 30, 2020